309 related articles for article (PubMed ID: 31142505)
1. The Sentinel Margin: Intraoperative
van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
[TBL] [Abstract][Full Text] [Related]
2. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
3. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
Gao RW; Teraphongphom NT; van den Berg NS; Martin BA; Oberhelman NJ; Divi V; Kaplan MJ; Hong SS; Lu G; Ertsey R; Tummers WSFJ; Gomez AJ; Holsinger FC; Kong CS; Colevas AD; Warram JM; Rosenthal EL
Cancer Res; 2018 Sep; 78(17):5144-5154. PubMed ID: 29967260
[TBL] [Abstract][Full Text] [Related]
4. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
[TBL] [Abstract][Full Text] [Related]
5. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent Molecular Imaging Can Improve Intraoperative Sentinel Margin Detection in Oral Squamous Cell Carcinoma.
Krishnan G; van den Berg NS; Nishio N; Kapoor S; Pei J; Freeman L; Lee YJ; Zhou Q; van Keulen S; Farkurnejad S; Condon J; Baik FM; Martin BA; Rosenthal EL
J Nucl Med; 2022 Aug; 63(8):1162-1168. PubMed ID: 35027369
[TBL] [Abstract][Full Text] [Related]
7. Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma.
van Keulen S; van den Berg NS; Nishio N; Birkeland A; Zhou Q; Lu G; Wang HW; Middendorf L; Forouzanfar T; Martin BA; Colevas AD; Rosenthal EL
Oral Oncol; 2019 Jan; 88():58-65. PubMed ID: 30616798
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative Molecular Imaging for
Fakurnejad S; Krishnan G; van Keulen S; Nishio N; Birkeland AC; Baik FM; Kaplan MJ; Colevas AD; van den Berg NS; Rosenthal EL; Martin BA
Front Oncol; 2019; 9():1476. PubMed ID: 31998640
[No Abstract] [Full Text] [Related]
9. Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Voskuil FJ; de Jongh SJ; Hooghiemstra WTR; Linssen MD; Steinkamp PJ; de Visscher SAHJ; Schepman KP; Elias SG; Meersma GJ; Jonker PKC; Doff JJ; Jorritsma-Smit A; Nagengast WB; van der Vegt B; Robinson DJ; van Dam GM; Witjes MJH
Theranostics; 2020; 10(9):3994-4005. PubMed ID: 32226534
[TBL] [Abstract][Full Text] [Related]
10. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
Lu G; van den Berg NS; Martin BA; Nishio N; Hart ZP; van Keulen S; Fakurnejad S; Chirita SU; Raymundo RC; Yi G; Zhou Q; Fisher GA; Rosenthal EL; Poultsides GA
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):753-764. PubMed ID: 32416764
[TBL] [Abstract][Full Text] [Related]
11. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL
Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094
[No Abstract] [Full Text] [Related]
12. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging.
Zhou Q; van den Berg NS; Kang W; Pei J; Nishio N; van Keulen S; Engelen MA; Lee YJ; Hom M; Vega Leonel JCM; Hart Z; Vogel H; Cayrol R; Martin BA; Roesner M; Shields G; Lui N; Gephart MH; Raymundo RC; Yi G; Granucci M; Grant GA; Li G; Rosenthal EL
J Nucl Med; 2022 Nov; 63(11):1693-1700. PubMed ID: 35332092
[TBL] [Abstract][Full Text] [Related]
13. Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.
Krishnan G; van den Berg NS; Nishio N; Juniper G; Pei J; Zhou Q; Lu G; Lee YJ; Ramos K; Iagaru AH; Baik FM; Colevas AD; Martin BA; Rosenthal EL
Theranostics; 2021; 11(15):7188-7198. PubMed ID: 34158844
[No Abstract] [Full Text] [Related]
14. A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent.
Steinkamp PJ; Voskuil FJ; van der Vegt B; Doff JJ; Schepman KP; de Visscher SAHJ; Kelder W; Jayalakshmi Y; Gao J; Sumer BD; van Dam GM; Witjes MJH
Mol Imaging Biol; 2021 Dec; 23(6):809-817. PubMed ID: 34031845
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma.
Lee YJ; Krishnan G; Nishio N; van den Berg NS; Lu G; Martin BA; van Keulen S; Colevas AD; Kapoor S; Liu JTC; Rosenthal EL
Laryngoscope; 2021 Mar; 131(3):529-534. PubMed ID: 33593036
[TBL] [Abstract][Full Text] [Related]
16. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
[TBL] [Abstract][Full Text] [Related]
17. Surgical margins in head and neck cancer: Intra- and postoperative considerations.
Thomas Robbins K; Triantafyllou A; Suárez C; López F; Hunt JL; Strojan P; Williams MD; Braakhuis BJM; de Bree R; Hinni ML; Kowalski LP; Rinaldo A; Rodrigo JP; Vander Poorten V; Nixon IJ; Takes RP; Silver CE; Ferlito A
Auris Nasus Larynx; 2019 Feb; 46(1):10-17. PubMed ID: 30172560
[TBL] [Abstract][Full Text] [Related]
18. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.
Rosenthal EL; Warram JM; de Boer E; Chung TK; Korb ML; Brandwein-Gensler M; Strong TV; Schmalbach CE; Morlandt AB; Agarwal G; Hartman YE; Carroll WR; Richman JS; Clemons LK; Nabell LM; Zinn KR
Clin Cancer Res; 2015 Aug; 21(16):3658-66. PubMed ID: 25904751
[TBL] [Abstract][Full Text] [Related]
19. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
20. Intraoperative Margin Assessment in Head and Neck Cancer: A Case of Misuse and Abuse?
Kubik MW; Sridharan S; Varvares MA; Zandberg DP; Skinner HD; Seethala RR; Chiosea SI
Head Neck Pathol; 2020 Jun; 14(2):291-302. PubMed ID: 32124417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
